Clinical Trial: Hop Extract Versus Soy Isoflavone Extract for Menopausal Symptoms (HOPES)

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07904390) titled 'Hop Extract Versus Soy Isoflavone Extract for Menopausal Symptoms (HOPES)' on Oct. 23.

Brief Summary: HOPES (Hops On Psychological and Estrogenic Symptoms in Menopause) is a randomized, double-blind, active-controlled nutritional intervention study in 120 peri- and postmenopausal women aged 45 to 60 years with moderate to severe menopausal symptoms. For 12 weeks, participants take one capsule per day of either a full spectrum hop (Humulus lupulus L.) extract or a soy isoflavone extract. Both products are marketed dietary supplements, and there is no placebo arm.

The main question is whether the hop extract, which combines prenylate...